Название документа

Powder for oral Ormaks suspension is shown for treatment of the infections caused by the microorganisms sensitive to azithromycin:

an infection of ENT organs (bacterial pharyngitis / tonsillitis, sinusitis, average otitis);
respiratory infection (bacterial bronchitis, community-acquired pneumonia);
an infection of leather and soft tissues the migrating erythema (initial stage of a disease of Lyme), an ugly face, impetigo, secondary pyodermatoses.
an infection which are transferred sexually: the simple genital infections caused by Chlamydia trachomatis.

Structure

Active ingredient: azithromycin;

200 mg of azithromycin contain

5 ml of suspension (in the form of a dihydrate);

Excipients: Natrium benzoicum (E 211), sucrose or sucrose from silicon dioxide colloidal, sodium phosphate, hydroxypropyl cellulose, xanthane gum, silicon dioxide colloidal, fragrance fruit "apricot". Does not contain dyes.

Contraindication

Hypersensitivity to active ingredient, other components of medicine or to other makrolidny antibiotics. In view of a theoretical possibility of an ergotism azithromycin should not be applied along with ergot derivatives.

Route of administration

For suspension preparation a container with powder should be turned that powder separated from a bottom, then by means of the dosing syringe to add 15 ml of boiled water of room temperature. After water addition to close a bottle and to stir up carefully before formation of uniform suspension. After that in a special frame of the label it is necessary to date suspension preparation. To store ready suspension in the fridge. Before each application suspension should be shaken up well. To accept suspension in 1 times a day in 1 hour prior to or in 2 hours after a meal. Directly after use of suspension the child needs to allow to drink several drinks of liquid to wash away and swallow residues of suspension in an oral cavity.

Feature of application

Pregnant

should appoint Azithromycin by

during pregnancy only according to vital indications.

Children

Ormaks in the form of suspension of 100 mg / 5 ml to apply

to children with the body weight from 5 to 15 kg. To children with body weight more than 15 kg to apply Ormaks in the form of suspension of 200 mg / 5 ml.

Drivers

Are not present data that azithromycin can worsen ability to steer motor transport or to work with other mechanisms, no, but it is necessary to consider a possibility of development of side reactions, such as dizziness, drowsiness, disorders of vision.

Overdose

Symptoms. At overdose, azithromycin observes the expressed nausea, vomiting, diarrhea, an abdominal pain, a reverse hearing loss.

Treatment. Intake of activated carbon and performing the general symptomatic and supporting treatment.

Side effects

from blood and lymphatic system: infrequently – a leukopenia, a neutropenia, an eosinophilia; it is unknown – thrombocytopenia, hemolytic anemia;
from mentality: infrequently – nervousness, insomnia; seldom – agitation; it is unknown – aggression, concern, the increased psychomotor activity, a delirium, hallucinations;
from nervous system: often – a headache; infrequently – dizziness, drowsiness, paresthesia, a dysgeusia; it is unknown - a faint, spasms, an anosmia, a parosmiya, an ageusia, a myasthenia gravis, a hypesthesia;
from organs of sight: often – visual frustration;
from organs of hearing: infrequently – a hearing disorder, vertigo; it is unknown – deterioration in hearing, including deafness and/or a ring in ears;
from heart: infrequently – palpitation; it is unknown – torsade de pointes (torsade de pointes), arrhythmia, including ventricular tachycardia (it was revealed that they are also called by other makrolidny antibiotics), lengthening of an interval of QT on the ECG;
from vessels: infrequently – inflows; it is unknown – arterial hypotension;
from a respiratory system: infrequently – dispnoe, nasal bleeding, breath dysfunctions, rhinitis;
from a digestive tract: very often – diarrhea; often – nausea, vomiting, discomfort in a stomach (pains/spasms); infrequently – gastritis, a meteorism, dyspepsia, a dysphagy, dryness in a mouth, an eructation, ulcers in an oral cavity, saliva hypersecretion, anorexia, a lock; it is unknown - discoloration of language, pancreatitis;

Interaction

Should appoint by

with care azithromycin along with other medicines which can extend QT interval.

Tsetirizin. At healthy volunteers at simultaneous use of azithromycin within 5 days from tsetiriziny 20 mg in an equilibrium state the phenomena of pharmacokinetic interaction or significant changes of an interval of QT were not observed.

Didanozin. At simultaneous application of daily doses in 1200 mg of azithromycin with didanoziny influence on pharmacokinetics of a didanozin in comparison with placebo was not revealed.

Ergot. Considering theoretical possibility of an ergotism, simultaneous introduction of azithromycin with derivatives of an ergot is not recommended.

Storage conditions

to Store

at a temperature not above 25 °C.
to Store
out of children's reach.
Ready suspension to store
no more than 5 days at a temperature from 2 °C to 8 °C.
to Store
out of children's reach.

Expiration date - 2 years.

Expiration date of ready suspension - 5 days.

Characteristics
Active ingredients	Azithromycin
Amount of active ingredient	40 mg/ml
Applicant	Sperko
Code of automatic telephone exchange	J01FA10 Azithromycin
Interaction with food	To
Light sensitivity	Not sensitive
Market status	The branded generic
Origin	Chemical
Prescription status	According to the prescription
Primary packing	container
Producer	SPERKO UKRAINE
Quantity in packing	20 ml
Release form	powder for internal use
Route of administration	Oral
Sign	Domestic
Storage temperature	from 5 °C to 25 °C
Trade name	Ormaks